Home » Topics » BioWorld Science

BioWorld Science
RSS

Transine Therapeutics secures funding to advance its novel class of therapeutic RNAs

June 2, 2021

Diverse cohort expands diabetes genomics

June 2, 2021

Copeptin is a prognostic marker in schizophrenia spectrum disorder

June 2, 2021

NIH announces first-in-human study of FluMos-v1 universal influenza vaccine

June 2, 2021

Valo Early Discovery identifies new HDAC8 inhibitors

June 2, 2021

Ventyx Biosciences synthesizes new TYK2 ligands

June 2, 2021

Dana-Farber Cancer Institute presents new PROTACs

June 2, 2021

Heptares Therapeutics patents GPR52 agonists

June 2, 2021

Revolution Medicines discloses SOS1 inhibitors

June 2, 2021

Novel inhalable liposome formulations of antiviral drugs against COVID-19

June 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...